Healthcare -
Biotechnology - NASDAQ - US
$ 70.925
-0.33 %
$ 13.5 B
Market Cap
32.09
P/E
BMRN - COST OF REVENUE
Cost of Revenue BMRN - BioMarin Pharmaceutical Inc.
580 M
LAST VALUE
9.53%
2 YEAR CAGR
10.05%
5 YEAR CAGR
16.16%
10 YEAR CAGR